We are live on ! Find out more
Commonwealth Equity Services

Commonwealth Equity Services Portfolio holdings

AUM $71.6B
1-Year Est. Return 21.08%
This Fund
S&P 500
This Quarter Est. Return
-1.92%
1 Year Est. Return
+21.08%
3 Year Est. Return
+64.42%
5 Year Est. Return
+73.55%
10 Year Est. Return
+239.11%
AUM
$70.7B
AUM Growth
+$2.25B
Cap. Flow
+$4.44B
Cap. Flow %
6.28%
Top 10 Hldgs %
18.43%
Holding
4,336
New
249
Increased
2,450
Reduced
1,387
Closed
164
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CBUS icon
4076
Cibus
CBUS
$130M
$43K ﹤0.01%
22,853
+652
+3% +$1.53K
TARA icon
4077
Protara Therapeutics
TARA
$226M
$43K ﹤0.01%
10,000
-27,000
-73% -$121K
BTBT icon
4078
Bit Digital
BTBT
$484M
$42K ﹤0.01%
20,634
+3,903
+23% +$11.2K
CCCC icon
4079
C4 Therapeutics
CCCC
$376M
$42K ﹤0.01%
26,100
-2,780
-10% -$8.29K
CCLD icon
4080
CareCloud
CCLD
$94.3M
$42K ﹤0.01%
+30,495
New +$89.8K
LXRX icon
4081
Lexicon Pharmaceuticals
LXRX
$1.02B
$42K ﹤0.01%
90,864
-10,284
-10% -$6.49K
PYXS icon
4082
Pyxis Oncology
PYXS
$165M
$42K ﹤0.01%
43,250
+17,000
+65% +$22.7K
VFF icon
4083
Village Farms International
VFF
$235M
$41K ﹤0.01%
67,004
+5,854
+10% +$4.27K
ATAI icon
4084
AtaiBeckley Inc
ATAI
$2.66B
$40K ﹤0.01%
29,157
BCDA icon
4085
BioCardia
BCDA
$12.7M
$40K ﹤0.01%
+15,583
New +$37.7K
GEVO icon
4086
Gevo
GEVO
$396M
$40K ﹤0.01%
34,564
+11,000
+47% +$18.4K
MGF
4087
Aberdeen Government Markets Income Fund
MGF
$91.6M
$40K ﹤0.01%
12,710
+42
+0.3% +$130
WOLF icon
4088
Wolfspeed
WOLF
$1.2B
$38K ﹤0.01%
12,334
-24,423
-66% -$143K
WWR icon
4089
Westwater Resources
WWR
$51M
$37K ﹤0.01%
66,250
+10,250
+18% +$7.99K
DYAI icon
4090
Dyadic International
DYAI
$43.4M
$36K ﹤0.01%
26,679
-2,935
-10% -$4.42K
NB
4091
NioCorp Developments
NB
$603M
$36K ﹤0.01%
18,324
+8,150
+80% +$16.4K
TELA icon
4092
TELA Bio
TELA
$30.9M
$35K ﹤0.01%
28,441
CTMX icon
4093
CytomX Therapeutics
CTMX
$705M
$34K ﹤0.01%
54,243
+1,000
+2% +$775
NG icon
4094
NovaGold Resources
NG
$2.6B
$34K ﹤0.01%
11,573
+1,458
+14% +$4.69K
ONCY
4095
Oncolytics Biotech
ONCY
$96.9M
$34K ﹤0.01%
61,114
+1,000
+2% +$731
OTLK icon
4096
Outlook Therapeutics
OTLK
$263M
$34K ﹤0.01%
28,151
+2,536
+10% +$4.45K
TNYA icon
4097
Tenaya Therapeutics
TNYA
$168M
$34K ﹤0.01%
59,500
+15,000
+34% +$14.8K
CGEN icon
4098
Compugen
CGEN
$216M
$33K ﹤0.01%
22,706
+1,915
+9% +$3.74K
EMX
4099
DELISTED
EMX Royalty
EMX
$33K ﹤0.01%
16,019
ATOS icon
4100
Atossa Therapeutics
ATOS
$22.9M
$31K ﹤0.01%
3,067

Similar funds

Commonwealth Equity Services's Q1 2025 Portfolio in Review

As of Q1 2025, Commonwealth Equity Services held 4,336 positions worth $70.7B, up 3.3% from $68.4B the previous quarter. Its ten largest holdings account for 18% of the portfolio.

Commonwealth Equity Services deployed $4.44B of net new capital in Q1 2025, opening 249 new positions and adding to 2,450 existing holdings. Its largest new stake was Federated Hermes MDT Large Cap Growth ETF: 6,272,869 shares worth $162M.

By sector, the portfolio is most concentrated in Technology at 11% of assets, down from 13% a quarter earlier, followed by Financials and Consumer Discretionary.

On the sell side, the largest reduction was iShares Russell Top 200 Growth ETF, an estimated $160M trimmed.

  • Commonwealth Equity Services's largest Q1 2025 buy was Federated Hermes MDT Large Cap Growth ETF: 6,272,869 shares worth $162M.
  • Commonwealth Equity Services added most to State Street SPDR Portfolio Developed World ex-US ETF in Q1 2025, an estimated $185M increase.
  • Commonwealth Equity Services's biggest Q1 2025 reduction was iShares Russell Top 200 Growth ETF, cutting an estimated $160M.
  • Commonwealth Equity Services fully exited Innovator Emerging Markets 10 Buffer ETF - Quarterly in Q1 2025, selling an estimated $6.05M.
  • Commonwealth Equity Services's ten largest holdings make up 18% of its $70.7B portfolio in Q1 2025.
  • Commonwealth Equity Services opened 249 new positions and closed 164 in Q1 2025.
  • Commonwealth Equity Services's portfolio value rose 3.3% quarter-over-quarter to $70.7B.

Based on Commonwealth Equity Services's 13F filing for Q1 2025, filed 9 May 2025.